Coronary heart disease and lipid-modifying treatment in african american patients

This publication has 41 references indexed in Scilit:

• Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR * Trial)
  Published by Elsevier ,2003
• Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
  JAMA, 2002
• Multi-Ethnic Study of Atherosclerosis: Objectives and Design
  American Journal of Epidemiology, 2002
• AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update
  Circulation, 2002
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• LDL Size in African Americans, Hispanics, and Non-Hispanic Whites
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• The PDAY Study: Natural History, Risk Factors, and Pathobiology
  Annals of the New York Academy of Sciences, 1997
• Efficacy and Tolerability of Lovastatin in 459 African-Americans With Hypercholesterolemia**This study was supported in part by grants to clinical sites from ClinTrials, Inc., Research Triangle Park, North Carolina, which was responsible for the execution of this study sponsored by Merck & Co, Inc., Rahway, New Jersey.
  The American Journal of Cardiology, 1996
• Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the multiple risk factor intervention trial
  The American Journal of Cardiology, 1986